{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:24Z","timestamp":1793039724129,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lfs.2019.116648","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:15:10Z","timestamp":1562757310000},"page":"116648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling"],"prefix":"10.1016","volume":"232","author":[{"given":"Dongya","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.116648_bb0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/IGC.0000000000000517","article-title":"Multiple cycles of neoadjuvant chemotherapy associated with poor survival in bulky stage IIIC and IV ovarian cancer","volume":"25","author":"Ren","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.lfs.2019.116648_bb0010","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2019.116648_bb0015","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2019.116648_bb0020","first-page":"171","article-title":"Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer","volume":"32","author":"Wang","year":"2011","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.lfs.2019.116648_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrc2089","article-title":"Tumour microenvironment: laminin 332 in squamous-cell carcinoma","volume":"7","author":"Marinkovich","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2019.116648_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2220\/biomedres.33.309","article-title":"Laminin-5gamma2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma","volume":"33","author":"Masuda","year":"2012","journal-title":"Biomed. Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/jop.12121","article-title":"Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma","volume":"43","author":"Marangon Junior","year":"2014","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.lfs.2019.116648_bb0040","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1074\/mcp.M112.023507","article-title":"Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues","volume":"12","author":"Kosanam","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.lfs.2019.116648_bb0045","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1210\/jc.2013-2994","article-title":"Laminin-5gamma-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR","volume":"99","author":"Garg","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2019.116648_bb0050","first-page":"8089","article-title":"Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin","volume":"61","author":"Hlubek","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00428-006-0354-7","article-title":"Overexpression of laminin-5 gamma2 chain in clear cell carcinoma of the ovary","volume":"450","author":"Kato","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lfs.2019.116648_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PGP.0b013e3181808021","article-title":"Relation between laminin-5 gamma 2 chain and cell surface metalloproteinase MT1-MMP in clear cell carcinoma of the ovary","volume":"28","author":"Kato","year":"2009","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.lfs.2019.116648_bb0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fonc.2017.00332","article-title":"Human epididymis protein 4 promotes events associated with metastatic ovarian cancer via regulation of the extracelluar matrix","volume":"7","author":"Ribeiro","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2019.116648_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2019.116648_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.biopha.2018.08.044","article-title":"MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2","volume":"107","author":"Duan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2019.116648_bb0080","first-page":"2661","article-title":"MicroRNA665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2019.116648_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1499-3872(14)60277-0","article-title":"WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells","volume":"13","author":"Wei","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.lfs.2019.116648_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(91)90092-D","article-title":"Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes","volume":"65","author":"Carter","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.116648_bb0095","first-page":"5596","article-title":"Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells","volume":"59","author":"Koshikawa","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7827-1-71","article-title":"Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium","volume":"1","author":"Choi","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.lfs.2019.116648_bb0105","first-page":"10026","article-title":"Effect of CXCR4 silencing with shRNA on MAPK signaling in ovarian cancer","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2019.116648_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-015-2542-8","article-title":"MAPK\/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy","volume":"410","author":"Zhang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2019.116648_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mc.22903","article-title":"S100A11 promotes cell proliferation via P38\/MAPK signaling pathway in intrahepatic cholangiocarcinoma","volume":"58","author":"Zhang","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2019.116648_bb0120","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1007\/s13277-015-4245-x","article-title":"NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1\/2\/p38 MAPK signal pathway","volume":"37","author":"Xu","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2019.116648_bb0125","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3892\/mmr.2014.2490","article-title":"Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatinresistant ovarian cancer","volume":"10","author":"Xie","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2019.116648_bb0130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0002-9440(10)64933-4","article-title":"Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas","volume":"160","author":"Niki","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.116648_bb0135","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ajpath.2012.02.028","article-title":"MAPK\/ERK-dependent translation factor hyperactivation and dysregulated laminin gamma2 expression in oral dysplasia and squamous cell carcinoma","volume":"180","author":"Degen","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.116648_bb0140","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase kinase","volume":"273","author":"Favata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.116648_bb0145","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-06-1150","article-title":"Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1\/2 inhibitor","volume":"13","author":"Yeh","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0150","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","article-title":"Genomic organization of microRNAs","volume":"222","author":"Olena","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2019.116648_bb0155","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-10-2132","article-title":"MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab","volume":"17","author":"Nishida","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0160","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.2147\/OTT.S92314","article-title":"MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma","volume":"8","author":"Fu","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.lfs.2019.116648_bb0165","first-page":"71","article-title":"MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2","volume":"10","author":"Qin","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2019.116648_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317697579","article-title":"MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3","volume":"39","author":"Zhong","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2019.116648_bb0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3727\/096504017X15016337254623","article-title":"MicroRNA-125a-5p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by downregulation of ErbB3","volume":"27","author":"Li","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.lfs.2019.116648_bb0180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopha.2015.12.027","article-title":"MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression","volume":"80","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2019.116648_bb0185","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1002\/jcb.27124","article-title":"MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1","volume":"119","author":"Yan","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2019.116648_bb0190","first-page":"5119","article-title":"MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression","volume":"15","author":"Cao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2019.116648_bb0195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopha.2018.09.100","article-title":"MiR-125a-5p suppresses bladder cancer progression through targeting FUT4","volume":"108","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2019.116648_bb0200","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.2147\/CMAR.S161990","article-title":"miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA","volume":"10","author":"Yang","year":"2018","journal-title":"Cancer Manag. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519305740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519305740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:42:07Z","timestamp":1793036527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519305740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0024320519305740"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116648","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116648"}}